Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.

Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association

El Khoudary, Samar R., Aggarwal, Brooke, Beckie, Theresa M., Hodis, Howard N., Johnson, Amber E., Langer, Robert D., Limacher, Marian C., Manson, JoAnn E., Stefanick, Marcia L., Allison, Matthew A., On behalf of the American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing · 2020 · Circulation

Abstract

Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable increase in the risk for this disease after menopause and typically develop coronary heart disease several years later than men. This observation led to the hypothesis that the menopause transition (MT) contributes to the increase in coronary heart disease risk. Over the past 20 years, longitudinal studies of women traversing menopause have contributed significantly to our understanding of the relationship between the MT and CVD risk. By following women over this period, researchers have been able to disentangle chronological and ovarian aging with respect to CVD risk. These studies have documented distinct patterns of sex hormone changes, as well as adverse alterations in body composition, lipids and lipoproteins, and measures of vascular health over the MT, which can increase a woman’s risk of developing CVD postmenopausally. The reported findings underline the significance of the MT as a time of accelerating CVD risk, thereby emphasizing the importance of monitoring women’s health during midlife, a critical window for implementing early intervention strategies to reduce CVD risk. Notably, the 2011 American Heart Association guidelines for CVD prevention in women (the latest sex-specific guidelines to date) did not include information now available about the contribution of the MT to increased CVD in women. Therefore, there is a crucial need to discuss the contemporary literature on menopause and CVD risk with the intent of increasing awareness of the significant adverse cardiometabolic health–related changes accompanying midlife and the MT. This scientific statement provides an up-to-date synthesis of the existing data on the MT and how it relates to CVD.

Overview

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000000912

Cites

233 of 233 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 233 references

Research works printed but not linked: 6

  1. Santoro, N, El Khoudary, SR, Sokalska, A, Szmuilowicz, ED, Wolfman, W. Menopause. In: Menopause Practice: A Clinician’s Guide. Pepper Pike, OH: The North American Menopause Society; 20191–21.
  2. Kochanek, KD, Murphy, SL, Xu, J, Tejada-Vera, B. Deaths: final data for 2014. Natl Vital Stat Rep. 2016;65:1–122.
  3. Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. Hyattsville, MD: National Center for Health Statistics;; 2016.
  4. Ogden, CL, Carroll, MD, Fryar, CD, Flegal, KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 2015:1–8.
  5. 2018 Physical Activity Guidelines Advisory Committee. 2018 Physical Activity Guidelines Advisory Committee Scientific Report. Washington, DC: US Department of Health and Human Services; 2018.
  6. 10.1093/ajcn.82.3.651 · doi:10.1093/ajcn.82.3.651

Cited by

See all 1,219

Metadata

Authors
El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., Limacher, M. C., Manson, J. E., Stefanick, M. L., Allison, M. A., & On behalf of the American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing
Venue
Circulation
Published
2020-12-22
Volume
142
Issue
25
Pages
e506-e532
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3109735199
Cited by
1,219
References
233
Citations by year
2026: 357 · 2025: 259 · 2024: 202 · 2023: 191 · 2022: 144 · 2021: 61 · 2020: 1
FWCI
15.18
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
perimenopause, cardiovascular risk, coronary artery disease, women's cardiovascular health, ovarian aging, sex hormones, middle-aged women, cardiometabolic risk, body composition, vascular health, cardiovascular prevention guidelines, early prevention
MeSH terms
Adult, Age Factors, Aged, American Heart Association, Hypolipidemic Agents, Cardiovascular Diseases, Female, Health Status, Humans, Menopause, Middle Aged, Primary Prevention, Risk Factors, Sex Factors, Time Factors, United States, Estrogen Replacement Therapy, Women's Health, Treatment Outcome, Risk Assessment, Risk Reduction Behavior, Time-to-Treatment, Protective Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. https://app.cochat.ai/papers/10.1161/cir.0000000000000912
The paper
El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., Limacher, M. C., Manson, J. E., Stefanick, M. L., Allison, M. A., & On behalf of the American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing. (2020). Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation. https://doi.org/10.1161/cir.0000000000000912

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.